DRP1 Rabbit Polyclonal Antibody
cat.: HA500487
Product Type: Rabbit polyclonal IgG, primary antibodies
Species reactivity: Human, Mouse, Rat
Applications: WB, IF-Cell, FC
Clonality: Polyclonal
Form: Liquid
Storage condition: Store at +4℃ after thawing. Aliquot store at -20℃. Avoid repeated freeze / thaw cycles.
Storage buffer: PBS (pH7.4), 0.1% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Concentration: 1ug/ul
Purification: Protein A affinity purified.
Molecular weight: Predicted band size: 82 kDa
Isotype: IgG
Immunogen: Recombinant protein within human DRP1 aa 1-736 / 736.
Positive control: A549 cell lysate, 293 cell lysate, HCT116 cell lysate, Hela cell lysate, NIH/3T3 cell lysate, PC-12 cell lysate, NIH/3T3, 293T.
Subcellular location: Cytoplasm, cytosol, Golgi apparatus, Endomembrane system, Mitochondrion outer membrane, Peroxisome, Membrane, clathrin-coated pit, Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane.
Recommended Dilutions:
  WB
  IF-Cell
  FC

1:1,000
1:200
1:500-1:1,000
Uniprot #: SwissProt: O00429 Human | Q8K1M6 Mouse | O35303 Rat
Alternative names: DLP1 dnm1l DNM1L_HUMAN Dnm1p/Vps1p-like protein dnml1 DRP1 DVLP Dymple Dynamin 1 like Dynamin family member proline-rich carboxyl-terminal domain less Dynamin like protein Dynamin related protein 1 Dynamin-1-like protein Dynamin-like protein 4 Dynamin-like protein Dynamin-like protein IV Dynamin-related protein 1 DYNIV 11 EMPF EMPF1 FLJ41912 HdynIV VPS1
Images
HA500487_1.jpg Fig1: Western blot analysis of DRP1 on different lysates with Rabbit anti-DRP1 antibody (HA500487) at 1/1,000 dilution.

Lane 1: A549 cell lysate
Lane 2: 293 cell lysate
Lane 3: HCT116 cell lysate
Lane 4: Hela cell lysate
Lane 5: NIH/3T3 cell lysate
Lane 6: PC-12 cell lysate

Lysates/proteins at 10 µg/Lane.

Predicted band size: 82 kDa
Observed band size: 82 kDa

Exposure time: 17 seconds;

4-20% SDS-PAGE gel.

Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA500487) at 1/1,000 dilution was used in 5% NFDM/TBST at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1:300,000 dilution was used for 1 hour at room temperature.
HA500487_2.jpg Fig2: Immunocytochemistry analysis of NIH/3T3 cells labeling DRP1 with Rabbit anti-DRP1 antibody (HA500487) at 1/200 dilution.

Cells were fixed in 4% paraformaldehyde for 10 minutes at 37 ℃, permeabilized with 0.05% Triton X-100 in PBS for 20 minutes, and then blocked with 2% negative goat serum for 30 minutes at room temperature. Cells were then incubated with Rabbit anti-DRP1 antibody (HA500487) at 1/200 dilution in 2% negative goat serum overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
HA500487_3.jpg Fig3: Flow cytometric analysis of 293T cells labeling DRP1.

Cells were fixed and permeabilized. Then stained with the primary antibody (HA500487, 1ug/ml) (red) compared with Rabbit IgG Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody (HA1121) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black).
HA500487_4.jpg Fig4: Flow cytometric analysis of NIH/3T3 cells labeling DRP1.

Cells were fixed and permeabilized. Then stained with the primary antibody (HA500487, 1ug/ml) (red) compared with Rabbit IgG Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody (HA1121) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black).
Note: All products are “FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE”.